During the past decade, Orlando Immunology Center conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 55 clinical trials were completed, i.e. on average, 148.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 15 clinical trials were completed. i.e. 107.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orlando Immunology Center" #1 sponsor was "Gilead Sciences" with 60 trials, followed by "Bristol-Myers Squibb" with 15 trials sponsored, "TaiMed Biologics Inc." with 6 trials sponsored, "Community Research Initiative of New England" with 5 trials sponsored and "Alexion" with 5 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Immunology Center" #1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Westat" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "GlaxoSmithKline" with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Orlando Immunology Center" are "HIV Infections" (34 trials), "HIV-1 Infection" (16 trials), "HIV" (14 trials), "Hepatitis C" (13 trials) and "HIV-1-infection" (10 trials). Many other conditions were trialed in "Orlando Immunology Center" in a lesser frequency.

Most popular intervention types in "Orlando Immunology Center" are "Drug" (106 trials), "Biological" (13 trials), "Device" (2 trials), "Genetic" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "RBV" (11 trials), "FTC/TDF" (9 trials), "Ribavirin" (9 trials), "E/C/F/TAF" (8 trials) and "Sofosbuvir" (8 trials). Other intervention names were less common.

The vast majority of trials in "Orlando Immunology Center" are 118 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Orlando Immunology Center". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 98 completed trials in Orlando Immunology Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Orlando Immunology Center, 14 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 1 trials that are defined as “Not Applicable".

Orlando Immunology Center has several departments that took part in Clinical trials: "Orlando Immunology Center CRS" - 4 trials